Fig. 3: Route to diagnosis of newly diagnosed myeloma patients, those diagnosed from 1st January 2019–31st January 2020 (Pre-COVID, n = 110) and those diagnosed from 1st February 2020–31st July 2021 (Post-COVID, n = 213). | Blood Cancer Journal

Fig. 3: Route to diagnosis of newly diagnosed myeloma patients, those diagnosed from 1st January 2019–31st January 2020 (Pre-COVID, n = 110) and those diagnosed from 1st February 2020–31st July 2021 (Post-COVID, n = 213).

From: Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic

Fig. 3

*p < 0.05. OPD diagnosed through an outpatient consultation, EAD diagnosed through an emergency admission. SRE skeletal-related event, AKI acute kidney injury, SCC spinal cord compression, Cardio-Respiratory cardiovascular and/or respiratory compromise.

Back to article page